Agilent Technologies Inc
Change company Symbol lookup
Select an option...
A Agilent Technologies Inc
TIG Trean Insurance Group Inc
DICE Dice Therapeutics Inc
NUSI Nationwide Nasdaq-100® Risk-Managed Income ETF
TISI Team Inc
UIHC United Insurance Holdings Corp
BFI Burgerfi International Inc
COW iPath? Series B Bloomberg Livestock Subindex Total Return ETN
PYXS Pyxis Oncology Inc

Health Care : Life Sciences Tools & Services | Large Cap Growth
Company profile

Agilent Technologies, Inc. is engaged in providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets business offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics businesses are comprised of six areas of activity, providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. Its product categories include liquid chromatography systems and components and liquid chromatography mass spectrometry systems.


Last Trade
0.00 (0.00%)
B/A Size

Market Hours

Closing Price
Day's Change
-3.28 (-2.39%)
B/A Size
Day's High
Day's Low

10-day average volume:



6 providers
March 20, 2023
Agilent Announced as Instrument Business Outlook 2022 Company of the Year

Agilent Technologies Inc. (NYSE: A) announced today that it has been selected as Instrument Business Outlook (IBO) 2022 Company of the Year. IBO highlighted Agilent's increased growth in revenues, operating profit, and net income, noting that the...(BusinessWire)

March 14, 2023
Market Disruptor Axion BioSystems Rejects Agilent Technologies, Inc. Allegations

Axion BioSystems vigorously refutes a recent filing by Agilent Technologies, Inc. (NYSE: A) claiming patent infringement and false advertising. As a recognized biotechnology innovator and owner of numerous patents over 14 years, Axion BioSystems...(BusinessWire)

March 10, 2023
Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023

Agilent Technologies Inc. (NYSE: A) announced today a highly-anticipated end-to-end solution for digital pathology that brings together best-in-class products from Agilent, Visiopharm, Proscia(R), and Hamamatsu Photonics K.K. The announcement...(BusinessWire)

Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu

Agilent Technologies Inc. (NYSE: A) today announced it has partnered with Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, to incorporate their NanoZoomer range including the S360MD Slide scanner system into the Agilent...(BusinessWire)

March 09, 2023
Agilent Again Named One of Barron's 100 Most Sustainable Companies

For the sixth consecutive year, Agilent Technologies (NYSE: A) is ranked among the top 20 in Barron's list of America's 100 Most Sustainable Companies. The ranking is based on the performance of the 1,000 largest publicly held companies on a variety...(BusinessWire)

Agilent Announces Acquisition of e-MSion, Early-Stage Company Behind ECD Technology that Helps Accelerate Drug Development

Agilent Technologies Inc. (NYSE: A) today announced the acquisition of e-MSion, an early-stage company behind the innovative electron capture dissociation (ECD) technology known as the ExD cell. The ExD cell is a compact device for mass...(BusinessWire)

March 08, 2023
Agilent Announces Global Distribution Agreement with Proscia to Accelerate Data-Driven Precision Medicine

Agilent Technologies Inc. (NYSE: A) today announced a multi-year distribution agreement with Proscia(R) - a leader in digital pathology - to offer a comprehensive digital diagnostic pathology system. Combining Agilent's trusted pathology staining...(BusinessWire)

March 06, 2023
Agilent to Present at Barclays Global Healthcare Conference

Agilent Technologies Inc. (NYSE: A) today announced that Chief Financial Officer Bob McMahon will participate in a Q&A session at the Barclays Global Healthcare Conference in Miami Beach, Florida, on March 15 at 3:05 p.m. EST. (BusinessWire)

February 28, 2023
Agilent Reports First-Quarter Fiscal Year 2023 Financial Results

--Highlights: -- Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.76 billion for the first quarter ended January 31, 2023, an increase of 5% compared to the first quarter of 2022 and up 10% on a core(1) basis. (BusinessWire)

February 27, 2023
Agilent Announces Bravo NGS Automated Liquid Handling Platform with On-Deck Thermal Cycler

Agilent Technologies Inc. (NYSE: A) today announced the release of an on-deck thermal cycler (ODTC) that integrates with the Agilent Bravo NGS automated liquid handling platform. The optional ODTC accessory enables the Bravo platform to provide...(BusinessWire)

February 24, 2023
Agilent Announces Cell Analysis Workflow Automation for Immuno-Oncology, Virology, and Vaccine Development Markets

Agilent Technologies Inc. (NYSE: A) today announced their xCELLigence RTCA HT (real-time cell analysis high-throughput) platform now integrates with the BioTek BioSpa 8 Automated Incubator. Developed in response to market needs, this combination...(BusinessWire)

February 22, 2023
Agilent Announces Cash Dividend of 22.5 Cents Per Share

Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 22.5 cents per share of common stock will be paid on April 26, 2023, to all shareholders of record as of the close of business on April 4, 2023. (BusinessWire)

Agilent Inspires at SLAS2023, Highlighting Innovative Automated Workflow Solutions

Agilent Technologies Inc. (NYSE: A) announced today that it will highlight a suite of automated laboratory workflow solutions at the SLAS2023 International Conference and Exhibition held February 25 through March 1 in San Diego. Agilent is also...(BusinessWire)

February 16, 2023
Colorado Governor Polis Helps Agilent Break Ground on $725 Million Expansion of Manufacturing Operations in Frederick

Leaders from Agilent Technologies Inc. (NYSE: A) today joined Colorado Governor Jared Polis and local government officials to break ground on Agilent's $725 million investment to double manufacturing capacity of therapeutic nucleic acids in...(BusinessWire)

February 09, 2023
Agilent Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance

Agilent Technologies Inc. (NYSE: A) today announced the release of new NovoExpress software that introduces integrated compliance tools for NovoCyte flow cytometer systems. The compliance-enabling features enable users to meet regulatory...(BusinessWire)

January 23, 2023
Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test

Agilent Technologies Inc. (NYSE: A) today announced an agreement with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. The alliance will enable providers and patients throughout the United States to...(BusinessWire)

January 18, 2023
Agilent Included in Just Capital's 2023 List of Most Just Companies

Agilent Technologies Inc. (NYSE: A) is ranked 35 among the top 100 Most JUST companies, the fifth year the company has been included in the annual list by Just Capital and CNBC. Agilent also earned the top ranking in its sector for industry-leading...(BusinessWire)

January 09, 2023
Agilent Authorizes $2 Billion Share Repurchase Program

Agilent Technologies Inc. (NYSE: A) today announced that its board of directors has approved a new share repurchase program. The 2023 program authorizes the purchase of up to $2 billion of the company's common stock. (BusinessWire)

Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics

Agilent Technologies Inc. (NYSE: A) today announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the company's...(BusinessWire)

January 06, 2023
Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications

Agilent Technologies, Inc. (NYSE: A) today announced a partnership with Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company(R), to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis and to commercialize...(BusinessWire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.